N04.6
Nephrotic syndrome with dense deposit disease
Clinical Classification Guidelines
Inclusion Terms
- Nephrotic syndrome with C3 glomerulopathy with dense deposit disease
- Nephrotic syndrome with membranoproliferative glomerulonephritis, type 2
Medical Intelligence & Overview
Nephrotic syndrome with dense deposit disease, also known as C3 glomerulopathy or type 2 membranoproliferative glomerulonephritis, is a kidney disorder characterized by significant protein loss in the urine, low blood protein levels, swelling, and potential kidney damage. This condition involves abnormal immune system activity leading to damage in the tiny filters within the kidneys called glomeruli, which play a crucial role in filtering waste and excess fluids from the blood.
Causes & Symptoms
Clinical Causes: Abnormal activation of the complement system, part of the immune response, which causes damage to kidney tissue. Genetic mutations affecting complement regulation. Infections or immune system disorders that trigger immune complex formation. Idiopathic causes, meaning the exact cause is unknown in some cases. Rarely, certain medications or toxins may contribute to the disease.
Key Symptoms: Swelling in the legs, ankles, or around the eyes (edema). Foamy or frothy urine due to excess protein. Less common symptoms include weight gain, fatigue, and loss of appetite. High blood pressure in some cases. Potential decline in kidney function over time.
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition involves multiple steps. Initially, a healthcare provider reviews your medical history and symptoms, followed by laboratory tests. Urine analysis can detect abnormal protein levels and blood presence. Blood tests measure kidney function and look for low protein and high cholesterol levels. A kidney biopsy, where a small tissue sample is examined under a microscope, is often necessary to identify characteristic dense deposits within the glomeruli and confirm the diagnosis of dense deposit disease associated with nephrotic syndrome.
Treatment Protocols: Treatment strategies focus on controlling symptoms and slowing disease progression. Common approaches include: - **Medications:** Use of corticosteroids and immunosuppressive drugs to reduce immune activity. - **Blood pressure management:** Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to lower blood pressure and reduce protein leakage. - **Diuretics:** To manage swelling. - **Lipid-lowering agents:** Due to high cholesterol often present in nephrotic syndrome. - **Plasmapheresis:** In some cases, this procedure helps remove abnormal proteins or immune complexes from the blood. While these treatments can help manage the disease, ongoing medical supervision is essential to monitor kidney function and address complications promptly. Future research continues to explore targeted therapies for better disease control.
Clinical Advice & FAQs
Billing Guidance
Is N04.6 a billable ICD-10 code?
Yes, N04.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N04.6?
Clinical documentation must specify the nature of Nephrotic syndrome with dense deposit disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference